Format

Send to

Choose Destination
J Paediatr Child Health. 1997 Feb;33(1):52-4.

Preliminary study of glycopyrrolate in the management of drooling.

Author information

1
Crippled Children's Association of South Australia, Regency Park, South Australia, Australia.

Abstract

OBJECTIVE:

A study was undertaken to assess the efficacy of an oral anticholinergic drug, glycopyrrolate, in the management of drooling in children and young adults with disabilities.

METHODOLOGY:

Glycopyrrolate was used by 24 children and young adults for up to 28 months. Parents/carers were asked to complete a questionnaire on the effects of the drug on severity and frequency of drooling and to report any side-effects.

RESULTS:

Twenty-two questionnaires were returned. There was a statistically significant decrease in both severity and frequency of drooling with minimal side-effects reported.

CONCLUSION:

In this preliminary study, glycopyrrolate was found to be an effective and well-tolerated addition to the management of drooling in children with disabilities.

PMID:
9069045
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center